
The Hidden Cost of Fungal Cures: Why That 'Anti-Cancer Compound' Isn't Coming to Your Pharmacy Soon
Beyond the headlines of new fungal compounds and golden sharks, the real story in 'this week in science' is about biotech hype vs. clinical reality.

Beyond the headlines of new fungal compounds and golden sharks, the real story in 'this week in science' is about biotech hype vs. clinical reality.
The expansion of a Mayo school's science facilities isn't just good news; it exposes deep fault lines in Ireland's national science education strategy.

Forget the hype: Hyundai’s massive new facility isn't just 'technological advancement'; it’s a calculated land grab in the global **electric vehicle** supply chain.
Insider buys at PAR Technology (PAR) signal short-term confidence, but the real story is the brutal market consolidation ahead for restaurant technology.

J&J's MFN deal signals a major shift in US pharma manufacturing, but is this national security win actually a massive economic trap?

Forget Sudoku. The real cognitive revolution for aging isn't puzzles—it's heavy lifting. Unpacking the hard truth about strength training and the aging brain.

KPMG’s latest tech insights reveal a dangerous complacency. We dissect the hidden winners of the current technology boom.
Australia's new Technology Foreign Interference Taskforce isn't about security; it's about control. Unpacking the real winners and losers in this tech crackdown.

The new science on chronic sleep deprivation isn't just a health warning—it's an economic blueprint. Discover the hidden costs of the 6-hour grind.

Forget the hype. Thucydides' lessons on power, fear, and human nature are the definitive guide to understanding modern **military technology** and **geopolitical strategy**.

The EU's Digital Networks Act (DNA) promises regulation, but the real story is the strategic 'soft touch' on Big Tech. Dive into the hidden winners and losers.

England's first Men's Health Strategy is here, but the real crisis facing **male health** is being ignored.